Raymond James Financial Inc. acquired a new position in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) during the fourth ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - ...

Lantheus Holdings, Inc.'s stock soars 55%, fueled by Pylarify and strategic acquisitions in Alzheimer's and oncology. Click ...

Charles Schwab Investment Management Inc. cut its stake in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 0.5% in the fourth quarter, according to its most recent 13F filing with the ...

Paul Blanchfield, the President of $LNTH, sold 2,084 shares of the company on 03-05-2025 for an estimated $204,232. We received data on the trade from a recent SEC ...

Lantheus Holdings, Inc. (NASDAQ:LNTH) is a radiopharmaceutical company specializing in diagnostic and therapeutic products for cardiology, oncology, and neurology. It develops advanced imaging ...

Lantheus Holdings, Inc. (NASDAQ:LNTH), a $6.83 billion market cap leader in the development and commercialization of innovative diagnostic and therapeutic agents, has been the subject of intense ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...